• Boards, companies and individuals on workplace misconduct matters, including highly sensitive investigations, compliance and cultural assessments, and crisis management
• A Fortune 100 company in connection with sensitive allegations of sexual misconduct
• Acting CEO of a major not-for-profit in congressional investigation into historical sexual misconduct at the organization
• Major professional services firms, financial institutions and other companies in investigations involving the DOJ, SEC and other regulators
• A global financial institution in internal and DOJ investigations related to the so-called “Luanda Leaks,” involving corruption allegations against the daughter of the former president of Angola
• A global financial institution in the industry-wide investigations into hiring practices in China of relatives of government officials, which resulted in a no-action letter from the SEC
• The Swiss bank Neue Privat Bank in its landmark resolution with the DOJ, the first non-prosecution agreement and lowest fine for a Category 1 Swiss Bank 
• A major financial institution in an SEC inquiry into bank-managed and advisory accounts and sales of structured products
• Numerous broker-dealers, hedge funds and other financial institutions in investigations by state and federal regulators relating to alleged insider trading, market manipulation, and other securities law violations
• Pentax Medical Company in a DOJ investigation relating to the FDCA, which resulted in a deferred prosecution agreement
• A medical device manufacturer in an SEC investigation into financial disclosure issues
• The special committee of the board of directors of a healthcare company in an internal investigation
• A financial institution in an SEC and FINRA investigation into blue sheet reporting
• A high-frequency trading firm in an SEC inquiry relating to the high-frequency trading industry, which ended without enforcement action
• Major pharmaceutical companies in a number of matters, including federal grand jury investigations, as well as related civil and regulatory matters, including under the False Claims Act (FCA)
• Government contractors responding to civil investigative demands (CIDs) and the Federal Acquisition Regulation (FAR)

Because of the nature of Martine’s assignments, many of her most successful matters have not resulted in public charges and remain confidential.